EMBO Molecular Medicine: Archive
High impact EMBO Molecular Medicine to Publish Under Open Access Model – STM Publishing News
EMBO Molecular Medicine: Conquering new frontiers. - Abstract - Europe PMC
Jarno Drost on LinkedIn: Check out the cover of the October edition of EMBO Molecular Medicine…
Publications - ERA Lab
Research - SOLARIS National Synchrotron Radiation Centre - Jagiellonian University
EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria - Biotech Spain
emm_oa_160-1497612432000.jpg
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation | EMBO Molecular Medicine
Ovid - EMBO Molecular Medicine | Wolters Kluwer
EMBO Press to be fully Open Access – Press releases – EMBO
EMBO Molecular Medicine Impact Factor, Indexing, Ranking, Abbreviation 2023 - JournalsInsights
European Molecular Biology Organization - Wikipedia
Duchenne Muscular Distrophy: the importance of microbiota as a potential target for therapeutic interventions - Centro Dino Ferrari
Wiley-VCH - EMBO Molecular Medicine
Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo | EMBO Molecular Medicine
EMBO Molecular Medicine: 8 (4) | Medicine book, Molecular, Medicine
EMBO Mol. Medicine (@EmboMolMed@sciencemastodon.com) - Science Mastodon
Springer Nature and EMBO cooperate to publish the EMBO Press suite of journals – Press releases – EMBO
EMBO Molecular Medicine: Archive
Ferroptosis: When metabolism meets cell death
EMBO Molecular Medicine Template - EMBO Press
EMBO Mol. Medicine on X: "Happy New Year! Our first 2022 issue is online! Read fully #openaccess: https://t.co/KyxkWdTowD Reviews on #CaloricRestriction and biomarkers for #AlzheimersDisease, and articles on #CancerImmunotherapy (cover ...
EMBO Mol. Medicine (@EmboMolMed@sciencemastodon.com) - Science Mastodon
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type C1, and Batten disease — TIGEM
